Exchange: NASDAQ·Updated 07:30 PM EDT
CYRX logo

CYRX CryoPort Inc

$17.40
$0.45
(2.66%)
Today
Closed $17.35
$0.05
(0.29%)
After Hours
EarningsNov 3
Mkt Cap$855.97M
Vol479,871.00

About CYRX

Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
60

Bullish Sentiment

How do you feel about CYRX?

BigAllergies
$CYRX $ABBV $MRK These are the top 3 pharma companies right now by a combination of fundamentals and momentum
2
jaykza
$CYRX Given the Anthropic enzyme discovery news, pretty simple and compelling thesis for Cryoport growth prospects. Once $CYRX becomes a cold storage logistics provider for a treatment in Phase 1/2/3, there are massive switching costs. As they continue to add treatments as a leader in CGT treatment logistics and these will graduate up to commercially approved at some % rate. Over time, we will see S-curves stacking as these treatments ramp. The image is just to show the impact of these treatments graduating to commercial approval over time.
1

Advertisement|Remove ads.